Taro Pharmaceutical's market cap is currently ―. The company's EPS TTM is $1.215; its P/E ratio is 34.58; Taro Pharmaceutical is scheduled to report earnings on May 21, 2024, and the estimated EPS forecast is $0.31. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 23	Sep 22	Jun 22	Mar 22	Dec 21
Income Statement	-
Total Revenue	-	$ 130.50M	$ 156.66M	$ 143.26M	$ 138.98M
Gross Profit	-	$ 46.96M	$ 81.61M	$ 77.34M	$ 76.03M
EBIT	-	$ -6.82M	$ 13.98M	$ 21.28M	$ 36.99M
EBITDA	-	$ 201.00K	$ 20.95M	$ 27.94M	$ 43.45M
Net Income Common Stockholders	-	$ -2.81M	$ 14.08M	$ 27.40M	$ 26.31M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 730.31M	$ 839.49M	$ 806.25M	$ 820.75M	$ 787.08M
Total Assets	$ 2.08B	$ 2.11B	$ 2.12B	$ 2.18B	$ 2.12B
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 2.20M	$ 0.00
Net Debt	$ -730.31M	$ -839.49M	$ -806.25M	$ -818.54M	$ -787.08M
Total Liabilities	$ 348.79M	$ 401.00M	$ 406.28M	$ 464.92M	$ 426.46M
Stockholders Equity	$ 1.73B	$ 1.71B	$ 1.71B	$ 1.71B	$ 1.70B
Cash Flow	-
Free Cash Flow	-	$ 18.96M	$ -60.14M	$ 38.46M	$ -195.24M
Operating Cash Flow	-	$ 20.36M	$ -58.03M	$ 41.26M	$ -191.93M
Investing Cash Flow	-	$ -70.79M	$ 34.76M	$ -108.61M	$ -14.02M
Financing Cash Flow	-	$ 0.00	$ 0.00	$ 0.00	$ 0.00

Currency in USD

Taro Pharmaceutical Earnings and Revenue History

Income Statement >

Taro Pharmaceutical Debt to Assets

Balance Sheet >

Taro Pharmaceutical Cash Flow

Cash Flow >

Taro Pharmaceutical Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing